Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A $35 million gift from Marc and Lynne Benioff will accelerate research to transform prostate cancer treatment.
Quincy’s treatment would take him and his family to the frontier of using precision medicine to find a drug to save the infant’s life.
The initiative aims to leverage microbiome research into precision therapies.
“Radiation can cause cancer and non-cancer outcomes, but it does not cause every type of cancer and non-cancer outcome.”
Q&A with a palliative care expert
The technology that uncovered antibody has the potential to identify other autoimmune diseases.
In a win for abortion opponents, the Trump administration limits funding of research using fetal tissue.
Collaboration with Lazarex Cancer Foundation tests new ways to erase cost barriers in major public health issue.
The method identifies which targeted therapies, inadequate on their own, can be paired up to kill non-responsive cancers.
The discovery may help explain immunotherapy resistance and hints at new therapies.
The technique prevents transplant rejection in the lab, a major advance for stem cell therapies.
Researchers find some cancer cell lines are more sensitive to NSAID treatment.
An award from Cancer Research UK will help an international team determine the basis of one in four cancer deaths.
Approach prevents cancers from making proteins they need to grow and to evade the immune system, while leaving healthy cells unharmed.
Women who chose to participate in an organized breast cancer screening program had significantly lower mortality risk than women who didn’t.
New UCSF study analyzes prostate cancer deaths by race.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.